EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine

Reshma Ramachandran iD

Journal of Law, Medicine & Ethics · 2023

DOI: 10.1017/jme.2023.155 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Law, Medicine & Ethics, 2023. Verfasst von Reshma Ramachandran. Hauptthemen laut MEDLINE: Biomedical Research, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NIH-Moderna mRNA COVID-19 vaccine’s steep price increase raises concerns that this will be the new anchor for continued price hikes and underscores the need for upstream government intervention to enable greater accountability and stewardship of public biomedical research investment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomedical ResearchCOVID-19HumansCOVID-19 VaccinesGovernmentInvestments

Stichwörter der Autor:innen

COVID-19 VaccinesGovernment FinancingPharmaceutical PricesPublic InvestmentVaccines

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

ORCID-Profile: Reshma Ramachandran

Zitieren

APA

Ramachandran, R. (2023). If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine. Journal of Law, Medicine & Ethics. https://doi.org/10.1017/jme.2023.155

Vancouver

Ramachandran R. If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine. Journal of Law, Medicine & Ethics. 2023. doi:10.1017/jme.2023.155

BibTeX
@article{Ramachandran2023,
  author = {Ramachandran, Reshma},
  title = {If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine},
  journal = {Journal of Law, Medicine & Ethics},
  year = {2023},
  doi = {10.1017/jme.2023.155}
}
Kostenlos starten →